File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Vaccine submission with muscle electroporation

TitleVaccine submission with muscle electroporation
Authors
KeywordsDNA vaccine
Electroporation
Gene therapy
Muscle
Vaccine
Issue Date2008
PublisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine
Citation
Vaccine, 2008, v. 26 n. 15, p. 1805-1806 How to Cite?
AbstractModern electroporation has been widely and successfully used in gene therapies and drug submissions on large animals including human. The DNA vaccine submission was now focused on muscle electroporation and has been shown to be a perspective application. Here we review some potentials of this application and discuss some difficulties in practical works.
Persistent Identifierhttp://hdl.handle.net/10722/161609
ISSN
2021 Impact Factor: 4.169
2020 SCImago Journal Rankings: 1.585
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorYuan, TF-
dc.date.accessioned2012-09-04T01:32:04Z-
dc.date.available2012-09-04T01:32:04Z-
dc.date.issued2008-
dc.identifier.citationVaccine, 2008, v. 26 n. 15, p. 1805-1806-
dc.identifier.issn0264-410X-
dc.identifier.urihttp://hdl.handle.net/10722/161609-
dc.description.abstractModern electroporation has been widely and successfully used in gene therapies and drug submissions on large animals including human. The DNA vaccine submission was now focused on muscle electroporation and has been shown to be a perspective application. Here we review some potentials of this application and discuss some difficulties in practical works.-
dc.languageeng-
dc.publisherElsevier Ltd. The Journal's web site is located at http://www.elsevier.com/locate/vaccine-
dc.relation.ispartofVaccine-
dc.rightsNOTICE: this is the author’s version of a work that was accepted for publication in Vaccine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Vaccine, [VOL 26, ISSUE 15, 2008] DOI 10.1016/j.vaccine.2008.01.047-
dc.subjectDNA vaccine-
dc.subjectElectroporation-
dc.subjectGene therapy-
dc.subjectMuscle-
dc.subjectVaccine-
dc.subject.meshElectroporation-
dc.subject.meshHumans-
dc.subject.meshMuscles-
dc.subject.meshVaccination - methods-
dc.subject.meshVaccines, DNA - administration and dosage-
dc.titleVaccine submission with muscle electroporationen_US
dc.typeArticleen_US
dc.identifier.emailYuan, TF: yuantf@hku.hk-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.vaccine.2008.01.047-
dc.identifier.pmid18313811-
dc.identifier.scopuseid_2-s2.0-40849135487-
dc.identifier.hkuros170671-
dc.identifier.volume26-
dc.identifier.issue15-
dc.identifier.spage1805-
dc.identifier.epage1806-
dc.identifier.isiWOS:000255326700001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0264-410X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats